Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Retained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Medifast (MED) Non-Current Assets (2016 - 2025)

Medifast's Non-Current Assets history spans 16 years, with the latest figure at $46.3 million for Q4 2025.

  • For Q4 2025, Non-Current Assets fell 33.69% year-over-year to $46.3 million; the TTM value through Dec 2025 reached $236.0 million, down 18.17%, while the annual FY2025 figure was $46.3 million, 33.69% down from the prior year.
  • Non-Current Assets reached $46.3 million in Q4 2025 per MED's latest filing, down from $60.4 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $97.2 million in Q2 2022 to a low of $44.5 million in Q1 2021.
  • Average Non-Current Assets over 5 years is $76.9 million, with a median of $76.7 million recorded in 2021.
  • Peak YoY movement for Non-Current Assets: surged 118.96% in 2021, then plummeted 33.69% in 2025.
  • A 5-year view of Non-Current Assets shows it stood at $91.5 million in 2021, then rose by 2.15% to $93.4 million in 2022, then decreased by 8.08% to $85.9 million in 2023, then dropped by 18.71% to $69.8 million in 2024, then tumbled by 33.69% to $46.3 million in 2025.
  • Per Business Quant, the three most recent readings for MED's Non-Current Assets are $46.3 million (Q4 2025), $60.4 million (Q3 2025), and $62.9 million (Q2 2025).